# Will Anthropic (Nasdaq: ANT) close above its $83 IPO price on December 31, 2026?

> As of 20 November 2026, Prolepsia puts the chance of yes at 63%.

- Forecaster: Prolepsia (https://prolepsia.com)
- Forecast made: 2026-11-20
- Question type: Yes / no
- Resolves: 2027-01-02
- Status: Open
- Forecasts: 1
- Page: https://prolepsia.com/forecasts/sigma-prior-photon/will-anthropic-nasdaq-ant-close-above-its-83-ipo-price-on-december-31-2026
- Open in the app: https://app.prolepsia.com/library/9d1786bb-eb34-4bd0-8130-d92db2bed7ca

## Forecast

- Yes: 63%
- No: 37%

## How Prolepsia reasons

## TL;DR

Probability of Yes: 63.1%. Probability of No: 36.9%. Anthropic is more likely than not to close above $83 on December 31, but the November 20 price indication left only an 8.9% cushion, making the December lock-up release a meaningful risk.

## Context

Anthropic priced its IPO at [$83.00 per share on November 18](https://www.anthropic.com/news/anthropic-prices-initial-public-offering) and began trading as ANT on the [Nasdaq Global Select Market on November 19](https://nasdaqtrader.com/TraderNews.aspx?id=DTN2026-28). The 980 million shares represented $81.34 billion in gross offering value, including shares sold by existing holders ([final prospectus](https://www.sec.gov/Archives/edgar/data/2130357/000162828026074944/anthropicpbc-424b4.htm)). ANT closed its debut at $97.17, above the offer but below its opening trade.

The forecast is dated November 20, 2026, with 28 sessions through year-end, including the shortened November 27 and December 24 sessions ([Nasdaq calendar](https://www.nasdaqtrader.com/trader.aspx?id=calendar)). It is conditional on a qualifying close. The test is the official unadjusted regular-session close for Anthropic's Class A shares on December 31, subject to the stated split and fallback rules. Without a split, $83.01 is Yes and $83.00 is No. Neither a foreign quote nor an after-hours trade can resolve the question.

## Evidence

Large IPOs with a positive first day often retain some gain six weeks later, but the size of the remaining cushion matters more than the fact that the debut was positive. In one [large-IPO comparison](https://www.renaissancecapital.com/IPO-Center/Stats/Largest-US-IPOs), seven of ten names that debuted 5% to 35% above offer were still above their own offer 28 sessions later. Only six of those ten posted returns that would have kept ANT above $83 from a November 20 price near $91.35. The first count answers what happened to those companies from their own starting premiums. The second asks how their subsequent moves would compare with the smaller cushion ANT actually had.

A separate group of large IPOs found that 41 of 56 remained above their offer at the same point. Among 13 with first-day gains of 10% to 30%, nine stayed above offer. Eight of those 13 had subsequent returns that would have preserved the smaller cushion implied by a November 20 starting price of $92.40. The groups overlap, some acquired or delisted stocks lacked usable price histories, and some offer prices were not independently checked. The counts favor Yes, but a few names can move them materially. They also do not capture ANT's overnight fade directly.

SpaceX is a reminder of what the aggregate obscures. The closest comparison by offering size priced at $135, closed its June 12 debut at $160.95, joined the Nasdaq-100 on July 7, and ended the comparable window on July 24 at $115.07 ([SpaceX prospectus](https://www.sec.gov/Archives/edgar/data/1181412/000162828026042466/spaceexplorationtechnologi.htm)). It lost its IPO premium despite index entry. That is one case, not a template for ANT. It shows that an index addition and a double-digit debut gain can coexist with a close below the offer six weeks later.

ANT's own prices make the strongest case for treating the historical evidence with restraint. The stock opened at $111.50 on November 19 and [closed at $97.17](https://www.investing.com/equities/anthropic-historical-data), 17.1% above the $83 offer but 12.85% below the open. The Nasdaq Composite fell about 2.3% that day ([AP market recap](https://apnews.com/article/2f178054aea79d282e5ccf8d62f26a28)), so the entire reversal should not be read as a verdict on Anthropic alone. U.S. extended-hours snapshots around $92.51 and $92.60 pointed lower still ([Stocknear](https://www.stocknear.com/stocks/ANT), [Yahoo Finance](https://ca.finance.yahoo.com/quote/ANT/)).

The November 20 indications narrowed the cushion further. [Tradegate](https://www.tradegatebsx.com/orderbuch.php?isin=US03703U1079) showed a trade at €83.56 at 09:05 UTC and later quoted €82.82 bid and €82.96 ask at 09:50 UTC. The later midpoint converts to about $91.11 at the November 19 ECB reference rate. A U.S. premarket snapshot at 09:37 UTC was $91.65. These are observations from different venues and times, not conflicting official prices. Around $91.10, an 8.9% fall would take ANT to $83. From the $97.17 debut close it would have taken a 14.58% fall.

December brings both potential buyers and potential sellers. [MSCI confirmed](https://app2.msci.com/webapp/index_ann/DocGet?format=html&lang=en&pub_key=ZcAS5badq4U%3D) that it would add ANT after the November 30 close, effective December 1. FTSE Russell's notices pointed to December 14 for its U.S. indexes and December 21 for its global indexes, subject to eligibility. Nasdaq-100 entry was plausible but unconfirmed. On December 15, up to 174 million Class A shares and up to 129 million restricted Class N shares become eligible for release, subject to the applicable resale and conversion terms ([final prospectus](https://www.sec.gov/Archives/edgar/data/2130357/000162828026074944/anthropicpbc-424b4.htm)). The Class A tranche alone is about 18% of the original public offering share count. The next scheduled tranche is January 5, outside the forecast window.

## What's non-obvious

**The debut premium is not the remaining cushion.** The 17.1% gain measures the move from the offer price to the debut close. The relevant downside is the move from the latest price indication back to the offer. The [later Tradegate quote](https://www.tradegatebsx.com/orderbuch.php?isin=US03703U1079) is useful because it covers the same Class A shares and points in the same direction as U.S. extended-hours trading. It is not useful as a precise substitute for a regular-session Nasdaq price. The direction matters more than the last few cents of the conversion.

The same distinction applies to December flows. The [lock-up release](https://www.sec.gov/Archives/edgar/data/2130357/000162828026074944/anthropicpbc-424b4.htm) makes sales possible. It does not commit holders to sell. [Index entry](https://app2.msci.com/webapp/index_ann/DocGet?format=html&lang=en&pub_key=ZcAS5badq4U%3D) brings buying tied to a rebalance, not a standing bid at $83. With both events on the calendar, some trading can occur ahead of the announced dates. The key question is how much buying and selling remains once those expectations are reflected in the price.

## Uncertainties

The first gap is a liquid U.S. price after the overnight decline. The Tradegate midpoint is a quote, not a trade, and its dollar conversion uses the prior day's reference rate. Regular-session prices and volume would show whether buyers accept the lower level or whether it was mainly a product of thin trading. There was no verified ANT options quote at the forecast cutoff to check how much volatility traders were pricing into this window. The historical comparisons give a sense of how wide the moves can be, not a precise range for this stock.

The second gap is how much supply and demand will reach the market. Index announcements establish timing, not the net effect on price. Lock-up terms establish when shares can be sold, not whether holders will sell. Confirmed index decisions, trading volume around rebalances, and evidence of actual selling after December 15 would make those forces easier to judge. A renewed tech selloff could erase the cushion even without heavy insider selling; stronger tech prices could help ANT retain it even if some holders sell.

## Forecast history

| Date | Forecast |
|---|---|
| 2026-11-20 | 63% chance of yes |

## Sources Prolepsia read

- [Anthropic prices initial public offering \\ Anthropic](https://www.anthropic.com/news/anthropic-prices-initial-public-offering)
- [Data Technical News #2026 - 28 Anthropic, PBC Initial Public Offering on Nasdaq Global Select Market](https://nasdaqtrader.com/TraderNews.aspx?id=DTN2026-28)
- [final prospectus](https://www.sec.gov/Archives/edgar/data/2130357/000162828026074944/anthropicpbc-424b4.htm)
- [Largest U.S. IPOs](https://www.renaissancecapital.com/IPO-Center/Stats/Largest-US-IPOs)
- [Anthropic Stock Price History - Investing.com](https://www.investing.com/equities/anthropic-historical-data)
- [How major US stock indexes fared Thursday 11/19/2026](https://apnews.com/article/2f178054aea79d282e5ccf8d62f26a28)
- [Anthropic PBC (ANT) Stock Price, Financials & Forecast - Stocknear](https://www.stocknear.com/stocks/ANT)
- [Anthropic, PBC (ANT) Stock Price, News, Quote & History - Yahoo Finance](https://ca.finance.yahoo.com/quote/ANT)
- [Tradegate BSX](https://www.tradegatebsx.com/orderbuch.php?isin=US03703U1079)
- [US: ANTHROPIC A](https://app2.msci.com/webapp/index_ann/DocGet?format=html&lang=en&pub_key=ZcAS5badq4U%3D)

## The question

This question asks whether Anthropic, PBC (Nasdaq: ANT) will finish the final trading session of 2026 with a share price strictly above its initial public offering (IPO) price of $83.00 per share. Anthropic priced its IPO at $83.00 per share on November 18, 2026, and began trading on the Nasdaq Global Select Market under the ticker ANT on November 19, 2026. The company raised approximately $81.3 billion through the offering, making it the largest IPO in history at the time. ANT closed its first trading session on November 19, 2026, at approximately $97.17, representing a gain of roughly 17.1% relative to its IPO price. As of November 20, 2026, the question remains unresolved. The forecast concerns the official closing price of Anthropic's publicly traded Class A common stock on Thursday, December 31, 2026, which is expected to be the final regular Nasdaq trading session of the year. The central question is whether the stock will retain a positive return relative to its original $83.00 IPO price approximately six weeks after its market debut. Background sources include Anthropic's official IPO announcement (https://www.anthropic.com/news/anthropic-prices-initial-public-offering), Nasdaq's listing notice (https://nasdaqtrader.com/TraderNews.aspx?id=DTN2026-28), and reporting by the Associated Press on November 19, 2026.

### How it resolves

The question resolves YES if Anthropic's (Nasdaq: ANT) official, unadjusted regular-session closing share price on December 31, 2026, is strictly greater than $83.00 USD. The question resolves NO if that closing price is equal to or less than $83.00 USD. A closing price of exactly $83.00 resolves NO, while a closing price of $83.01 or higher resolves YES. The primary resolution source will be the official Nasdaq historical closing price for ANT, as reported by Nasdaq or its authorized market-data providers. If Nasdaq's historical data is unavailable, the closing price reported by Yahoo Finance or another established financial market-data provider may be used, provided it represents the official unadjusted closing price for the relevant trading session. The regular-session closing price will be used rather than the after-hours price, intraday high, intraday low, opening price, or volume-weighted average price. If trading in ANT is temporarily halted during the December 31 session but Nasdaq publishes an official closing price for that date, that price will determine resolution. If December 31, 2026, unexpectedly becomes a non-trading day, the official closing price from the most recent preceding Nasdaq trading session in December 2026 will be used. If ANT is permanently delisted, acquired, or otherwise ceases to trade before the resolution date, and no qualifying closing price can be established for the designated session, the question will be annulled rather than resolved using an earlier price. If Anthropic undergoes a stock split or reverse stock split before the resolution date, the $83.00 IPO benchmark will be adjusted proportionally to preserve an economically equivalent comparison. Official corporate-action records published by Nasdaq or Anthropic will determine the adjustment. If the necessary historical pricing information remains unavailable from all designated sources, the question will be annulled.

### Fine print

The relevant security is Anthropic, PBC's Class A common stock originally listed on Nasdaq under the ticker ANT, not privately held shares, derivatives, options, or other securities associated with Anthropic. All prices are denominated in US dollars per share. The question compares the stock's closing price with its original IPO offering price, not its opening trading price on November 19, 2026, or its first-day closing price. Ordinary cash dividends, if any, will not be added to the closing share price. After-hours trading on December 31, 2026, and subsequent price movements in 2027 will not affect resolution. If ANT changes its ticker symbol but remains the same publicly traded security, its official closing price under the successor ticker will be used. If Nasdaq and secondary market-data providers report conflicting values, Nasdaq's official closing price takes precedence. The outcome should be determined using the official closing price once available, without incorporating unrelated subsequent revisions to market commentary or analyst estimates. In the event of a stock split, the IPO comparison threshold will be adjusted using the cumulative split ratio; the unadjusted closing price of the resulting shares will then be compared against that adjusted threshold.

---

Prolepsia’s forecasting engine made this forecast: it researched the question, weighed the evidence and wrote the report on this page. A probability is not a promise; this one changes as the evidence does.
